Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0301133 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Suye Ran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Polyunsaturated Alkamides, Piperidines, Sulfones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Youth Scientific and Technological Talents Projects, Guizhou Provincial Science and Technology Projects.
Abstract (Originalsprache)
Purpose
Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD), which has a high risk of cirrhosis, liver failure, and hepatocellular carcinoma. Piperine (Pip) is an extract of plants with powerful anti-inflammatory effects, however, the function of Pip in NASH remains elusive. Here, we aim to explore the role of Pip in NASH and to find the possible mechanisms.
Methods
Methionine and choline-deficient (MCD) diets were used to induce steatohepatitis, methionine- and choline-sufficient (MCS) diets were used as the control. After Pip treatment, H&E staining, Oil Red O staining, hepatic triglyceride (TG) content and F4/80 expression were performed to analysis liver steatosis and inflammation; Masson’s staining, COL1A1 and α-SMA were detected liver fibrosis. Lipopolysaccharide (LPS) -treated AML12 cells were used to as the cell model to induce pyroptosis. Then, pyroptosis-related proteins, IL-1β and LDH release were detected in vivo and in vitro . Finally, NF-κB inhibitor, BAY11-7082, was used to further demonstrate the mechanism of Pip in NASH.
Results
The study found that Pip alleviated liver steatosis, inflammation, hepatocyte injury, and fibrosis in mice fed with MCD diets. Moreover, the pyroptosis markers (NLRP3, ASC, caspase-1 p20, and GSDMD), IL-1β and LDH release were decreased by Pip treatment. NF-κB activation was suppressed by Pip treatment and pyroptosis-related proteins were down regulated by BAY11-7082.
Conclusion
Pip ameliorates NASH progression, and the therapeutical effect was associated with inhibition of hepatocyte pyroptosis induced by NF-κB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guizhou Medical University, Guiyang, China.
- Department of Colorectal Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
ORCID-Profile: Yunhuan Zhen, Qi Liu
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Youth Scientific and Technological Talents Projects
- Guizhou Provincial Science and Technology Projects
- National Natural Science Foundation of China in 2020 by the Affiliated Hospital of Guizhou Medical University
- Marshall Joint Laboratory Project of Affiliated Hospital of Guizhou Medical University
- National Natural Science Foundation of Guizhou Medical University cultivation project
Zitieren
APA
Ran, S., Song, L., Yang, H., Yu, J., Zhen, Y., & Liu, Q. (2024). Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0301133
Vancouver
Ran S, Song L, Yang H, Yu J, Zhen Y, Liu Q. Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0301133
BibTeX
@article{Ran2024,
author = {Ran, Suye and Song, Lingyu and Yang, Hong and Yu, Jiangnan and Zhen, Yunhuan and Liu, Qi},
title = {Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0301133}
}
EUVIMED